Wolf‐Rüdiger Ulrich

953 total citations
19 papers, 849 citations indexed

About

Wolf‐Rüdiger Ulrich is a scholar working on Oncology, Physiology and Biochemistry. According to data from OpenAlex, Wolf‐Rüdiger Ulrich has authored 19 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Physiology and 7 papers in Biochemistry. Recurrent topics in Wolf‐Rüdiger Ulrich's work include Drug Transport and Resistance Mechanisms (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Wolf‐Rüdiger Ulrich is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Wolf‐Rüdiger Ulrich collaborates with scholars based in Germany, Italy and United Kingdom. Wolf‐Rüdiger Ulrich's co-authors include Volker Gekeler, W Ise, James F. Beck, Karl H. Sanders, Rainer Boer, Sabine Haas, Thomas Klein, Andreas Strub, Christian Heßlinger and Martin D. Lehner and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Wolf‐Rüdiger Ulrich

18 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolf‐Rüdiger Ulrich Germany 12 407 290 177 170 105 19 849
Anne Mahringer Germany 19 479 1.2× 479 1.7× 156 0.9× 127 0.7× 89 0.8× 29 1.2k
Peihua Lu Canada 14 656 1.6× 418 1.4× 220 1.2× 195 1.1× 92 0.9× 21 1.0k
Karl H. Sanders Germany 11 375 0.9× 335 1.2× 142 0.8× 63 0.4× 90 0.9× 20 806
Yasuto Kido Japan 13 499 1.2× 262 0.9× 252 1.4× 72 0.4× 51 0.5× 18 881
Stephen T. Ingalls United States 22 172 0.4× 657 2.3× 100 0.6× 131 0.8× 53 0.5× 42 1.1k
Jocelyn Yabut United States 16 471 1.2× 357 1.2× 273 1.5× 120 0.7× 96 0.9× 19 1.3k
Kinya Ohta Japan 17 344 0.8× 318 1.1× 231 1.3× 64 0.4× 43 0.4× 34 955
Petra Arndt Germany 13 848 2.1× 382 1.3× 432 2.4× 81 0.5× 101 1.0× 17 1.4k
Kumiko Noda Japan 12 243 0.6× 162 0.6× 136 0.8× 133 0.8× 37 0.4× 22 802
Jean‐Michel Scherrmann France 16 387 1.0× 339 1.2× 209 1.2× 79 0.5× 38 0.4× 27 968

Countries citing papers authored by Wolf‐Rüdiger Ulrich

Since Specialization
Citations

This map shows the geographic impact of Wolf‐Rüdiger Ulrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐Rüdiger Ulrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐Rüdiger Ulrich more than expected).

Fields of papers citing papers by Wolf‐Rüdiger Ulrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolf‐Rüdiger Ulrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐Rüdiger Ulrich. The network helps show where Wolf‐Rüdiger Ulrich may publish in the future.

Co-authorship network of co-authors of Wolf‐Rüdiger Ulrich

This figure shows the co-authorship network connecting the top 25 collaborators of Wolf‐Rüdiger Ulrich. A scholar is included among the top collaborators of Wolf‐Rüdiger Ulrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolf‐Rüdiger Ulrich. Wolf‐Rüdiger Ulrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Grädler, Ulrich, Thomas Fuchß, Wolf‐Rüdiger Ulrich, et al.. (2011). Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights. Bioorganic & Medicinal Chemistry Letters. 21(14). 4228–4232. 30 indexed citations
2.
Heßlinger, Christian, et al.. (2009). Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochemical Society Transactions. 37(4). 886–891. 85 indexed citations
3.
Lehner, Martin D., Degenhard Marx, Rainer Boer, et al.. (2006). In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3 H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase. Journal of Pharmacology and Experimental Therapeutics. 317(1). 181–187. 11 indexed citations
4.
Heßlinger, Christian, Andreas Strub, Martin D. Lehner, et al.. (2006). Potent and highly selective inhibition of the inducible nitric oxide synthase by BYK191023. 2006(Spring). 1 indexed citations
5.
Strub, Andreas, Wolf‐Rüdiger Ulrich, Christian Heßlinger, et al.. (2005). The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase. Molecular Pharmacology. 69(1). 328–337. 32 indexed citations
6.
Borchers, Christoph H., Rainer Boer, Kurt Klemm, et al.. (2002). Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry. Molecular Pharmacology. 61(6). 1366–1376. 4 indexed citations
7.
Borchers, Christoph H., Rainer Boer, Kurt Klemm, et al.. (2002). Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry. Molecular Pharmacology. 61(6). 1366–1376. 28 indexed citations
8.
Eltze, Manfrid, Rainer Boer, Martin C. Michel, et al.. (2001). In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(6). 649–662. 27 indexed citations
9.
Ferry, D., R. Boer, Richard Callaghan, & Wolf‐Rüdiger Ulrich. (2000). Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine. International Journal of Clinical Pharmacology and Therapeutics. 38(3). 130–140. 10 indexed citations
10.
11.
12.
Beck, James F., Frank Buchholz, Wolf‐Rüdiger Ulrich, et al.. (1998). Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative. Cancer Letters. 129(2). 157–163. 4 indexed citations
13.
Boer, R., et al.. (1996). Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers. European Journal of Cancer. 32(5). 857–861. 16 indexed citations
14.
Ulrich, Wolf‐Rüdiger, et al.. (1996). Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein. European Journal of Pharmacology. 295(2-3). 253–260. 15 indexed citations
15.
Boer, R., Christoph H. Borchers, Wolf‐Rüdiger Ulrich, et al.. (1996). Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor,. Biochemistry. 35(5). 1387–1396. 30 indexed citations
16.
Gekeler, Volker, W Ise, Karl H. Sanders, Wolf‐Rüdiger Ulrich, & James F. Beck. (1995). The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance. Biochemical and Biophysical Research Communications. 208(1). 345–352. 361 indexed citations
17.
Borchers, Christoph H., Wolf‐Rüdiger Ulrich, Kurt Klemm, et al.. (1995). B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.. Molecular Pharmacology. 48(1). 21–29. 21 indexed citations
18.
19.
Ulrich, Wolf‐Rüdiger & F. Mechelke. (1980). [Reactions of in vitro cultures of human fibroblasts, of HeLa-cells and of murine L-cells on application of a drug from Viscum album L. (author's transl)].. PubMed. 30(10). 1722–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Mahringer Breakdown of academic impact, for papers by Peihua Lu Breakdown of academic impact, for papers by Karl H. Sanders Breakdown of academic impact, for papers by Yasuto Kido Breakdown of academic impact, for papers by Stephen T. Ingalls Breakdown of academic impact, for papers by Jocelyn Yabut Breakdown of academic impact, for papers by Kinya Ohta Breakdown of academic impact, for papers by Petra Arndt Breakdown of academic impact, for papers by Kumiko Noda Breakdown of academic impact, for papers by Jean‐Michel Scherrmann
Rankless by CCL
2026